Rosette Lidereau
Impact in
- Cancer Research top 0.1%
- Breast Cancer Treatment Studies
- Oncology top 0.2%
- Cancer Immunotherapy and Biomarkers
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
Papers in
- Cancer Research 110
- Breast Cancer Treatment Studies 97
- Genetics 101
- BRCA gene mutations in cancer 68
- Genomic variations and chromosomal abnormalities 18
- Estrogen and related hormone effects 16
- Co-authors
- Ivan Bièche (141 shared papers)Robert Callahan (28 shared papers)Michel Vidaud (20 shared papers)Sengül Tozlu (20 shared papers)M.H. Champème (26 shared papers)Sophie Vacher (34 shared papers)Keltouma Driouch (37 shared papers)Charles G. Theillet (9 shared papers)
- Journals
- International Journal of Cancer (23 papers)British Journal of Cancer (14 papers)Genes Chromosomes and Cancer (11 papers)Oncogene (11 papers)JNCI Journal of the National Cancer Institute (8 papers)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
Rosette Lidereau
289 papers receiving 23k citations
Rosette Lidereau's Hit Papers
Peers
Comparison fields: 5 of 133
- Cancer Research 5.6k
- Oncology 5.3k
- Genetics 3.9k
- Immunology 2.6k
- Pathology and Forensic Medicine 2.2k
Countries citing papers authored by Rosette Lidereau
This map shows the geographic impact of Rosette Lidereau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosette Lidereau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosette Lidereau more than expected).
Fields of papers citing papers by Rosette Lidereau
This network shows the impact of papers produced by Rosette Lidereau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosette Lidereau. The network helps show where Rosette Lidereau may publish in the future.
Co-authors
The 25 scholars most cited alongside Rosette Lidereau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 290 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy Hit paper breakdown → | 2007 | 2660 |
| 2 | Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors Hit paper breakdown → | 2009 | 1668 |
| 3 | Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancer Hit paper breakdown → | 2006 | 953 |
| 4 | 2007 | 774 | |
| 5 | 2007 | 488 | |
| 6 | 2006 | 469 | |
| 7 | 2011 | 429 | |
| 8 | 1986 | 360 | |
| 9 | 1987 | 299 | |
| 10 | 1998 | 297 | |
| 11 | Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas. | 2003 | 297 |
| 12 | 2007 | 295 | |
| 13 | 1995 | 268 | |
| 14 | 1995 | 227 | |
| 15 | 1999 | 226 | |
| 16 | 2011 | 226 | |
| 17 | 2011 | 223 | |
| 18 | Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay. | 1999 | 221 |
| 19 | 1998 | 215 | |
| 20 | Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays. | 2001 | 215 |
About Rosette Lidereau
Rosette Lidereau is a scholar working on Cancer Research, Genetics, Pathology and Forensic Medicine, Oncology and Molecular Biology, having authored 290 papers that have together received 23.8k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (97 papers), BRCA gene mutations in cancer (68 papers), Breast Lesions and Carcinomas (61 papers), HER2/EGFR in Cancer Research (22 papers), Cancer-related Molecular Pathways (20 papers), Prostate Cancer Treatment and Research (19 papers), Genomic variations and chromosomal abnormalities (18 papers) and Estrogen and related hormone effects (16 papers). The work is most often cited by research in Cancer Research (5.6k citations), Oncology (5.3k citations), Genetics (3.9k citations), Immunology (2.6k citations) and Pathology and Forensic Medicine (2.2k citations). Rosette Lidereau has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Ivan Bièche, Robert Callahan, Michel Vidaud, Sengül Tozlu, M.H. Champème, Sophie Vacher, Keltouma Driouch, Charles G. Theillet, Alain Latil and Olivier Cussenot. Their work appears in journals such as International Journal of Cancer, British Journal of Cancer, Genes Chromosomes and Cancer, Oncogene and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.